Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations have?
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations has 190 citations in the OpenAlex counts ScholarIQ stores.
When was Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations published?
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations has 2020 year in the ScholarIQ index.
What is the open-access status of Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations?
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations has closed oa status in the ScholarIQ index.
What is the DOI of Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations?
The DOI for Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations is on the source record.
What is the PMID of Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations?
The PMID for Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations is on the source record.
What is the OpenAlex record for Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations?
The OpenAlex for Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations is on the source record.